EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of the Isolated and Combined Impact of β-Glucan and Lacticaseibacillus rhamnosus on Cystic Fibrosis Gut Microbiota Using a SHIME® System

Jazmín Viteri-Echeverría iD, Joaquim Calvo-Lerma iD, Jorge García-Hernández iD, Ana Heredia iD, Ana Andrés iD, Andrea Asensio-Grau iD

Nutrients · 2025

DOI: 10.3390/nu17233756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Jazmín Viteri-Echeverría und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Universitario de Ingeniería de Alimentos-Food UPV, Universitat Politècnica de València, Camino de Vera s/n, 46022 València, Spain. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Cystic Fibrosis, Lacticaseibacillus rhamnosus, Probiotics. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitat Politècnica de València, Spanish Ministry of Science and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cystic fibrosis (CF) is a genetic disorder that disrupts gut microbiota composition, promoting dysbiosis associated with chronic inflammation, impaired nutrient absorption, and poor clinical outcomes. While modulation of the intestinal microbiota through prebiotics, probiotics, and synbiotics has been proposed as a therapeutic strategy, clinical evidence remains limited, especially in children.

Objective

This study aimed to evaluate the impact of three supplementation strategies (a prebiotic (β-glucan), a probiotic (Lacticaseibacillus rhamnosus GG), and their synbiotic combination) on the gut microbiota and metabolic activity of a CF child faecal donor using a dynamic in vitro colonic fermentation model (SHIME®).

Methods

Microbial composition (16S rRNA gene sequencing), and metabolic activity (quantification of short-chain fatty acids (SCFAs), ammonia, and lactate) were analysed.

Results

Results showed that the prebiotic increased alpha diversity; while both the prebiotic and probiotic treatments significantly reduced Bacillota and increased Bacteroidota, modulating the Bacillota/Bacteroidota ratio. The synbiotic treatment showed the most beneficial overall profile, including enhanced production of SCFAs, particularly butyrate and propionate, and increased abundance of Faecalibacterium and Agathobacter, which are two bacterial genera generally associated with gut health. Notably, the synbiotic also reduced the relative abundance of potentially pathogenic genera such as Veillonella, Megasphaera, and Stenotrophomonas, but paralleled with an increase in Clostridium ss 1. Although the probiotic alone showed some positive effects, it was less effective overall compared to the prebiotic and synbiotic approaches.

Conclusions

These findings support the potential of synbiotic supplementation as a promising strategy to modulate gut dysbiosis in CF, though in vivo studies are needed to confirm the translational relevance of these results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeCystic FibrosisLacticaseibacillus rhamnosusProbioticsbeta-GlucansHumansPrebioticsFecesSynbioticsFatty Acids, VolatileFermentationDysbiosisChildColon

Stichwörter der Autor:innen

Bacillota/Bacteroidotabeta-glucancolonic fermentationdysbiosispediatricsshort-chain fatty acids

Substanzen

Prebioticsbeta-GlucansFatty Acids, Volatile

Autor:innen und Institutionen

  • Instituto Universitario de Ingeniería de Alimentos-Food UPV, Universitat Politècnica de València, Camino de Vera s/n, 46022 València, Spain.
  • ALISOST Group, Faculty of Pharmacy and Food Sciences, University of Valencia, Avinguda Vicent Andrés Estellés, 46100 València, Spain.
  • Advanced Center of Applied Microbiology (CAMA), Universitat Politècnica de València, Camino de Vera s/n, 46022 València, Spain.
  • Departament de Didàctica de les Ciències Experimentals i Socials, University of Valencia, 46022 València, Spain.

ORCID-Profile: Jazmín Viteri-Echeverría, Joaquim Calvo-Lerma, Jorge García-Hernández, Ana Heredia, Ana Andrés, Andrea Asensio-Grau

Förderung

  • Universitat Politècnica de València
  • Spanish Ministry of Science and Innovation

Zitieren

APA

Viteri-Echeverría, J., Calvo-Lerma, J., García-Hernández, J., Heredia, A., Andrés, A., & Asensio-Grau, A. (2025). Assessment of the Isolated and Combined Impact of β-Glucan and Lacticaseibacillus rhamnosus on Cystic Fibrosis Gut Microbiota Using a SHIME® System. Nutrients. https://doi.org/10.3390/nu17233756

Vancouver

Viteri-Echeverría J, Calvo-Lerma J, García-Hernández J, Heredia A, Andrés A, Asensio-Grau A. Assessment of the Isolated and Combined Impact of β-Glucan and Lacticaseibacillus rhamnosus on Cystic Fibrosis Gut Microbiota Using a SHIME® System. Nutrients. 2025. doi:10.3390/nu17233756

BibTeX
@article{ViteriEcheverra2025,
  author = {Viteri-Echeverría, Jazmín and Calvo-Lerma, Joaquim and García-Hernández, Jorge and Heredia, Ana and Andrés, Ana and Asensio-Grau, Andrea},
  title = {Assessment of the Isolated and Combined Impact of β-Glucan and Lacticaseibacillus rhamnosus on Cystic Fibrosis Gut Microbiota Using a SHIME® System},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17233756}
}
Kostenlos starten →